Filing Details
- Accession Number:
- 0001209191-14-038146
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-30 20:00:18
- Reporting Period:
- 2014-05-28
- Filing Date:
- 2014-05-30
- Accepted Time:
- 2014-05-30 20:00:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 858803 | Avanir Pharmaceuticals Inc. | AVNR | Pharmaceutical Preparations (2834) | 330314804 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1534986 | Md Joao Siffert | 20 Enterprise, Suite 200 Aliso Viejo CA 92656 | Svp, R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-05-28 | 13,547 | $5.18 | 230,980 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2014-05-28 | 10,547 | $0.00 | 10,547 | $1.85 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 24,609 | 2021-12-15 | No | 4 | M | Direct |
Footnotes
- Represents the weighted-average price at which shares were sold within a range between $5.15 and $5.20. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- Includes previously reported shares of common stock underlying Restricted Stock Grants granted to the Reporting Person, which are subject to certain vesting conditions. Following the sales reported on this Form 4, the Reporting Person has a total of 185,938 options to purchase shares of common stock that are vested and immediately exercisable and a total of 221,171 options to purchase shares of common stock that have not yet vested. Following the sales reported on this Form 4, the Reporting Person also has 211,045 unvested Restricted Stock Units, of which 43,000 are performance-based Restricted Stock Units.
- The option was granted on December 15, 2011 and vests with respect to one-quarter of the underlying shares upon the first anniversary of the grant date, and then with respect to the remaining shares quarterly thereafter over the next three years.
- Includes previously reported options granted to the Reporting Person, which are subject to certain vesting conditions.
Billionaire Hedge Funds
